Andritz AG (ADRZY)
OTCMKTS · Delayed Price · Currency is USD
14.25
-1.25 (-8.06%)
Jul 31, 2025, 10:23 AM EDT
Ligand Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 463.9 | 496.5 | 510.2 | 409.6 | 325.5 | 207.1 | Upgrade |
Depreciation & Amortization | 226 | 223.7 | 216.7 | 235.5 | 228.7 | 231 | Upgrade |
Loss (Gain) From Sale of Assets | -2.6 | -3.8 | -7.4 | -34.5 | -12.3 | -8.4 | Upgrade |
Asset Writedown & Restructuring Costs | 2.3 | 2.3 | 8.3 | 17.3 | 10 | 25.1 | Upgrade |
Loss (Gain) on Equity Investments | -0.6 | -18.2 | -2.4 | -0.8 | 3.7 | 4.3 | Upgrade |
Other Operating Activities | 106.4 | 159.2 | 95.1 | 63.9 | -42 | 81.4 | Upgrade |
Change in Accounts Receivable | 0.8 | 0.8 | -222.3 | -208.3 | -247.3 | -115.1 | Upgrade |
Change in Inventory | 9.9 | 9.9 | -50.4 | -193 | -100.8 | 42.5 | Upgrade |
Change in Unearned Revenue | -109.7 | -109.7 | -182.4 | 434.2 | 257.3 | -249.7 | Upgrade |
Change in Other Net Operating Assets | -199.7 | -124.2 | 9.6 | -13.1 | 106.8 | 243.3 | Upgrade |
Operating Cash Flow | 496.7 | 636.5 | 375 | 710.8 | 529.6 | 461.5 | Upgrade |
Operating Cash Flow Growth | -34.88% | 69.73% | -47.24% | 34.22% | 14.76% | -43.83% | Upgrade |
Capital Expenditures | -193.8 | -179.5 | -170.8 | -155 | -110.3 | -87.9 | Upgrade |
Sale of Property, Plant & Equipment | 11.9 | 16.5 | 15.6 | 46.2 | 32.2 | 21.4 | Upgrade |
Cash Acquisitions | -90.6 | -36.9 | -36.4 | -62 | -30.5 | - | Upgrade |
Investment in Securities | 88.9 | -7.6 | 458.5 | -19.7 | -182 | -169.6 | Upgrade |
Investing Cash Flow | -183.6 | -207.5 | 266.9 | -190.5 | -290.6 | -236.1 | Upgrade |
Long-Term Debt Issued | - | 161.4 | 136.4 | 28.2 | 70.4 | 21.7 | Upgrade |
Long-Term Debt Repaid | - | -546.4 | -347.2 | -149.6 | -286.3 | -120.2 | Upgrade |
Net Debt Issued (Repaid) | -113.2 | -385 | -210.8 | -121.4 | -215.9 | -98.5 | Upgrade |
Issuance of Common Stock | 11 | 11.7 | 8.5 | - | - | - | Upgrade |
Repurchase of Common Stock | -116.6 | -116.6 | - | -16 | -4.7 | -18.1 | Upgrade |
Common Dividends Paid | -253.8 | -248.5 | -207.7 | -163.2 | -99.2 | -49.7 | Upgrade |
Other Financing Activities | -9.9 | -14.9 | -0.6 | -0.7 | -35.6 | -20.7 | Upgrade |
Financing Cash Flow | -482.5 | -753.3 | -410.6 | -301.3 | -355.4 | -187 | Upgrade |
Foreign Exchange Rate Adjustments | -49.3 | -14.5 | -26.3 | -4 | 44.7 | -81 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0.6 | -3.7 | 0.1 | - | 0.7 | -0.2 | Upgrade |
Net Cash Flow | -219.3 | -342.5 | 205.1 | 215 | -71 | -42.8 | Upgrade |
Free Cash Flow | 302.9 | 457 | 204.2 | 555.8 | 419.3 | 373.6 | Upgrade |
Free Cash Flow Growth | -48.43% | 123.80% | -63.26% | 32.55% | 12.23% | -46.59% | Upgrade |
Free Cash Flow Margin | 3.80% | 5.49% | 2.36% | 7.36% | 6.49% | 5.57% | Upgrade |
Free Cash Flow Per Share | 3.08 | 4.60 | 2.05 | 5.60 | 4.21 | 3.76 | Upgrade |
Cash Interest Paid | 38.9 | 38.9 | 34.4 | 19.1 | 36.3 | 40.3 | Upgrade |
Cash Income Tax Paid | 152.3 | 152.3 | 193.4 | 167.2 | 140.4 | 93.2 | Upgrade |
Levered Free Cash Flow | -98.91 | 333.36 | 59.96 | 514.55 | 536.25 | 278.3 | Upgrade |
Unlevered Free Cash Flow | -78.41 | 355.42 | 83.27 | 534.74 | 558.87 | 303.49 | Upgrade |
Change in Net Working Capital | 460.9 | 71.2 | 372 | -104 | -154.7 | 2.43 | Upgrade |
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.